Using augmented reality to assist in rectal cancer surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance minimally invasive surgical procedures for rectal cancer by integrating image-guided surgery tools that utilize augmented reality (AR). The approach involves overlaying preoperative 3D anatomical models onto real-time surgical images during robotic-assisted and laparoscopic surgeries. AI algorithms will be developed to improve the visibility of surgical instruments, thereby optimizing the surgical view. The pilot phase includes creating 3D virtual reconstructions of the pelvis and rectum to assess the feasibility of this technology in complex surgical anatomy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Indication for radical transabdominal surgery for primary rectal cancer
* Resection and anastomosis or abdominal-perineal amputation surgery
* Signature of informed consent
* Patient's age ≥18 years.
* CT images acquired in the arterial venous and urographic phase with section thickness:1.25/2.5 mm, level range:0.8/0.2 mm.
* Pelvic MRI images acquired with section thickness of 1.5 mm or images acquired with 3 tesla MRI.

Exclusion Criteria:

* Patients who have already undergone previous rectal surgery
* Relapse of previous rectal neoplasm
* Neoplasm located in other pelvic organs, infiltrating the rectum
* Indication for endoscopic or transanal treatment
* Disease with peritoneal localisation (carcinosis)
* Surgery for palliative purposes
* Imaging performed elsewhere

Where it's running

• IRCCS Azienda Ospedaliero-Universitaria di Bologna
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: matteo rottoli, MD — IRCCS Azienda Osperaliero-Universitaria di Bologna
• Study coordinator: angela belvedere, MD, PHD
• Email: angela.belvedere@aosp.bo.it
• Phone: +390512144466

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Neoadjuvant treatment for locally advanced rectal cancer

  This study is testing a new chemotherapy treatment for people with locally advanced rectal cancer to see if it works better than the standard treatment before surgery.

  Recruiting Phase 2 Menoufia University · Shibīn al Kawm, Menoufia · NCT06812728

• Imaging method for digestive system cancer using targeted PET scans

  This study is testing a new type of PET scan to see if it can better help doctors find and diagnose cancers in the digestive system.

  Recruiting RenJi Hospital · Shanghai, Shanghai Municipality · NCT06715839

• Treatment for advanced colon and rectal cancer using immune cells

  This study is testing a new treatment that uses the patient's own immune cells combined with other medications to see if it can help people with advanced colon and rectal cancer feel better and live longer.

  Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT06530303

• Adaptive radiotherapy using a new linear accelerator for cancer treatment

  This study is testing a new way to adjust radiation therapy for cancer patients each day based on changes in their tumors to see if it improves treatment.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT06116019

• Machine learning system to assist in robot-assisted surgery for rectal cancer

  This study is testing a new machine learning system to see if it can help surgeons perform robot-assisted surgery for rectal cancer more accurately and improve patient outcomes.

  Recruiting Technische Universität Dresden · Dresden, Saxony · NCT05652361

• Improving care for rural patients with solid tumors

  This study is testing a new support program to see if it helps rural patients with solid tumors start and finish their treatment faster compared to usual care.

  Recruiting at 14 sites University of Colorado, Denver · Aurora, Colorado and 13 other locations · NCT04916990

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.